Increasing genomic instability during cancer therapy in a patient with Li-Fraumeni syndrome

Background: Li-Fraumeni syndrome (LFS) is a cancer predisposition disorder characterized by germline mutations of the p53 tumor-suppressor gene. In response to DNA damage, p53 stimulates protective cellular processes including cell-cycle arrest and apoptosis to prevent aberrant cell proliferation. C...

Full description

Bibliographic Details
Main Authors: Nadine Schuler, Jan Palm, Sabine Schmitz, Yvonne Lorat, Claudia E. Rübe
Format: Article
Language:English
Published: Elsevier 2017-12-01
Series:Clinical and Translational Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630817300344